## Revenue and Profitability##

**Company C009** has shown a consistent upward trend in revenue from Q1 2020 to Q2 2025. Starting at $9,500,000 in Q1 2020, revenue grew to $27,900,000 by Q2 2025. This growth is mirrored in the gross profit, which increased from $5,400,000 in Q1 2020 to $18,100,000 in Q2 2025. The gross margin percentage has also seen an overall improvement, starting at 56.8% in Q1 2020 and reaching 64.5% in Q2 2025.

## Operating Expenses and Income##

Operating expenses (opex) have also increased over the period, from $6,000,000 in Q1 2020 to $13,600,000 in Q2 2025. This increase in opex is driven by rising R&D, selling, and administrative expenses. Despite the rise in operating expenses, the company has transitioned from operating losses in the earlier quarters of 2020 (e.g., -$800,000 in Q1 2020) to significant operating income, reaching $1,780,000 in Q2 2025.

## Net Income and Earnings Per Share##

The company began with a net loss of -$855,000 in Q1 2020, with a basic EPS of -0.11. By Q2 2025, C009 has achieved a net income of $1,720,000, with a basic EPS of 0.21. This demonstrates a strong recovery and growth in profitability over the observed period.

## Cash Flow and Liquidity##

Free cash flow has fluctuated but generally shows an improving trend, moving from a negative -$410,000 in Q1 2020 to a positive $790,000 in Q2 2025. Cash and equivalents have also grown substantially, from $3,600,000 in Q1 2020 to $8,400,000 in Q2 2025.

## Assets and Liabilities##

Total assets have steadily increased from $17,000,000 in Q1 2020 to $22,000,000 in Q2 2025. This growth in assets is accompanied by a manageable increase in total liabilities, from $6,300,000 in Q1 2020 to $8,200,000 in Q2 2025. Consequently, shareholders' equity has seen a consistent rise, from $10,700,000 in Q1 2020 to $13,800,000 in Q2 2025, indicating a strengthening equity base. Accounts receivable and property, plant, and equipment have also seen growth over the period. Notably, inventory levels have remained at $0 throughout the entire period.
